| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2024―Nov―15 |
Understanding the influence of COVID-19 on pancreatic exocrine and endocrine function: сlinical and pathogenetic insights and their correlation with infection severity |
M.E. Zharova, E.L. Nikonov, I.O. Ivanikov, Yu.V. Grigoryeva |
| 2 |
[GO] |
2024―Jun―14 |
Diabetes- associated factors in hospitalized COVID-19 patients with concomitant type 2 diabetes mellitus: focus on mean in-hospital glycemic values |
D. V. Belkina, T. A. Nekrasova, L. G. Strongin, E. M. Durygina, M. Yu. Rodina |
| 3 |
[GO] |
2024―Mai―25 |
The therapeutic potential of the use of gliclazide MV in combination with COVID-19 and type 2 diabetes mellitus |
D. V. Belikina, T. A. Nekrasova, L. G. Strongin, E. M. Durygina, M. Yu. Rodina |
| 4 |
[GO] |
2024―Mai―25 |
Course of coronavirus infection in patients with type 2 diabetes mellitus |
Z. Sh. Khamidullina, D. Sh. Avzaletdinova, T. V. Morugova, N. Sh. Zagidullin, D. F. Gareeva |
| 5 |
[GO] |
2024―Mai―23 |
The therapeutic potential of the use of gliclazide MV in combination with COVID-19
and type 2 diabetes mellitus |
D.V. Belikina, T. A Nekrasova, L.G. Strongin, E. M. Durygina, M. Yu. Rodina |
| 6 |
[GO] |
2024―Mai―23 |
Course of coronavirus infection in patients with type 2 diabetes mellitus |
Z. Sh. Khamidullina, D. Sh. Avzaletdinova, T.V. Morugova, N. Sh. Zagidullin, D. F. Gareeva |
| 7 |
[GO] |
2024―Jan―23 |
Developing central diabetes insipidus following neurohypophysitis during the convalescent period after recovering from covid-19: presentation of a clinical case and literature review |
E. A. Starostina, E. S. Drachuk, E. G. Przhiyalkovskaya, N. M. Platonova, E. A. Troshina |
| 8 |
[GO] |
2023―Jul―19 |
Some aspects of diagnosis, course and prediction of outcomes of a new coronavirus infection in patients with diabetes mellitus |
A. P. Volynkina, Yu. V. Khodarina, P. I. Kazakova, E. A. Volynkina, N. V. Naumova, I. O. Elizarova |
| 9 |
[GO] |
2022―Jun―17 |
Obesity in the era of COVID-19 pandemic: factor of poor prognosis |
Оleg Е. Iryshkin, Aleksey V. Taganov |
| 10 |
[GO] |
2022―Jun―17 |
Experience with the application of novel antiviral drugs in patients with comorbidities during the pandemic |
Vladimir A. Petrov, Aleksandr L. Potapov, Tatiana I. Ledovskaya, Aleksei V. Taganov |
| 11 |
[GO] |
2022―Jun―14 |
Coagulation disorders and their impact on increased clinical risk in patients with COVID-19 and concomitant diabetes mellitus |
|
| 12 |
[GO] |
2022―Jun―14 |
COVID-19 Vaccines |
|
